Effects of 12-month, 2000IU/day vitamin D supplementation on treatment naïve and vitamin D deficient Saudi type 2 diabetic patients

References

1. ↵
   1. Wild S,
   2. Roglic G,
   3. Green A,
   4. Sicree R,
   5. King H

   (2004) Global prevalence of diabetes. Diabetes Care 27:1047–1053.

   OpenUrlAbstract/FREE Full Text
2. ↵
   1. Al-Daghri NM,
   2. Al-Attas OS,
   3. Alokail MS,
   4. Alkharfy KM,
   5. Yousef M,
   6. Sabico SL,
   7. et al.

   (2011) Diabetes mellitus type 2 and other chronic non-communicable diseases in the central region, Saudi Arabia (Riyadh cohort 2): a decade of an epidemic. BMC Med 9:76.

   OpenUrlCrossRefPubMed
3. ↵
   1. Al-Daghri NM,
   2. Al-Attas OS,
   3. Alokail MS,
   4. Alkharfy KM,
   5. Yakout SM,
   6. Sabico SB,
   7. et al.

   (2011) Parent-offspring transmission of adipocytokine levels and their asociations with metabolic traits. PLoS One 6:e18182.

   OpenUrlCrossRefPubMed
4. ↵
   1. Zhong Y,
   2. Lin PJ,
   3. Cohen JT,
   4. Winn AN,
   5. Neumann PJ

   (2015) Cost-utility analyses in diabetes: a systematic review and implications from real-world evidence. Value Health 18:308–314.

   OpenUrlPubMed
5. ↵
   1. Usluogullari CA,
   2. Balkan F,
   3. Caner S,
   4. Ucler R,
   5. Kaya C,
   6. Ersoy R,
   7. Cakir B

   (2015) The relationship between microvascular complications and vitamin D deficiency in type 2 diabetes. BMC Endocr Disord 15:33.

   OpenUrl
6. ↵
   1. Holick MF

   (2007) Vitamin D deficiency. New Engl J Med 357:266–281.

   OpenUrlCrossRefPubMedWeb of Science
7. ↵
   1. Hussain AN,
   2. Alkhenizan AH,
   3. El Shaker M,
   4. Raef H,
   5. Gabr A

   (2014) Increasing trends and significance of hypovitaminosis D: a population-based study in the kingdom of Saudi Arabia. Arch Osteoporos 9:190.

   OpenUrl
8. ↵
   1. Alfawaz H,
   2. Tamim H,
   3. Alharbi S,
   4. Aljaser S,
   5. Tamimi W

   (2014) Vitamin D status among patients visiting a tertiary care center in Riyadh, Saudi Arabia: a retrospective review of 3475 cases. BMC Public Health 14:159.

   OpenUrl
9. ↵
   1. Sheth JJ,
   2. Shah A,
   3. Sheth FJ,
   4. Trivedi S,
   5. Lele M,
   6. Shah N,
   7. et al.

   (2015) Does vitamin D play a role in type 2 diabetes? BMC Endocrine Disorders 15:5.

   OpenUrl
10. ↵
    1. Prasad P,
    2. Kochlar A

    (2015) Interplay of vitamin D and metabolic syndrome: a review. Diabetes Metab Syndr 6:pii: S1871-4021(15)00027-2.
11. ↵
    1. Al-Daghri NM,
    2. Alkharfy KM,
    3. Al-Othman A,
    4. El-Kholie E,
    5. Moharram O,
    6. Alokail MS,
    7. et al.

    (2012) Vitamin D supplementation as an adjuvant therapy for patients with t2DM: an 18-month prospective intervention study. Cardiovasc Diabetol 11:85.

    OpenUrlCrossRefPubMed
12. ↵
    1. Alkharfy KM,
    2. Al-Daghri NM,
    3. Sabico SB,
    4. Al-Othman A,
    5. Moharram O,
    6. Alokail MS,
    7. et al.

    (2013) Vitamin D supplementation in patients with diabetes mellitus type 2 on different therapeutic regimens: a one-year prospective study. Cardiovasc Diabetol 12:113.

    OpenUrlPubMed
13. ↵
    1. Wallace TM,
    2. Levy JC,
    3. Matthews DR

    (2004) Use and abuse of HOMA modelling. Diabetes Care 27:1487–1495.

    OpenUrlAbstract/FREE Full Text
14. ↵
    1. Yao P,
    2. Lu L,
    3. Liu G,
    4. Chen X,
    5. Sun L,
    6. Ye X,
    7. et al.

    (2015) A dose-response study of vitamin D3 supplementation in healthy Chinese: a 5-arm randomized, placebo-controlled trial. Eur J Nutr 19:[Epub ahead of print].
15. ↵
    1. Baziar N,
    2. Jafarian K,
    3. Shadman Z,
    4. Qorbani M,
    5. Khoshniat Nikoo M,
    6. Abd Mishani M

    (2014) Effect of therapeutic dose of vitamin D on serum adiponectin and glycemia in vitamin D insufficient or deficient type 2 diabetic patients. Iran Red Crescent Med J 16:e21458.

    OpenUrl
16. 1. Lee DY,
    2. Kwon AR,
    3. Ahn JM,
    4. Kim YJ,
    5. Chae HW,
    6. Kim DH,
    7. et al.

    (2015) Relationship between serum 25-hydroxyvitamin D concentration and risks of metabolic syndrome in children and adolescents from Korean National health and Nutrition Examination Survey 2008-2010. Ann Pediatr Endocrinol Metab 20:46–52.

    OpenUrl
17. ↵
    1. Pekkanen MP,
    2. Ukkola O,
    3. Hedberg P,
    4. Piira OP,
    5. Lepojarvi S,
    6. Lumme J,
    7. et al.

    (2015) Serum 25-hydroxyvitamin D is associated with major cardiovascular risk factors and cardiac structure and function in patients with coronary artery disease. Nutr Metab Cardiovasc Dis 25:471–478.

    OpenUrlCrossRefPubMed
18. ↵
    1. Pilz S,
    2. Gaksch M,
    3. Kienreich K,
    4. Grubler M,
    5. Verheyen N,
    6. Fahrleitner-Pammer A,
    7. et al.

    (2015) Effects of vitamin D on blood pressure and cardiovascular risk factors: a randomized controlled trial. Hypertension 65:1195–1201.

    OpenUrl
19. ↵
    1. Beveridge LA,
    2. Struthers AD,
    3. Khan F,
    4. Jorder R,
    5. Scragg R,
    6. Macdonal HM,
    7. et al.

    (2015) Effect of vitamin D supplementation on blood pressure: a systematic review and meta-analysis incorporating individual patient data. JAMA Intern Med 175:745–754.

    OpenUrl
20. ↵
    1. Al-Zahrani MK,
    2. Elnasieh AM,
    3. Alenezi FM,
    4. Almoushawah AA,
    5. Almansour M,
    6. Alshahrani F,
    7. et al.

    (2014) A 3-month oral vitamin D supplementation marginally improves diastolic blood pressure in Saudi patients with type 2 diabetes mellitus. Int J Clin Exp Med 7:5421–5428.

    OpenUrl
21. ↵
    1. Al-Daghri NM,
    2. Alkharfy KM,
    3. Al-Saleh Y,
    4. Al-Attas OS,
    5. Alokail MS,
    6. Al-Othman A,
    7. et al.

    (2012) Modest reversal of metabolic syndrome manifestations with vitamin D status correction: a 12-month prospective study. Metabolism 61:661–666.

    OpenUrlPubMed
22. ↵
    1. Al-Daghri NM,
    2. Alfawaz H,
    3. Aljohani NJ,
    4. Al-Saleh Y,
    5. Wani K,
    6. Alnaami AM,
    7. et al.

    (2014) A 6-month “self-monitoring” lifestyle modification with increased sunlight exposure modestly improves vitamin D status, lipid profile and glycemic status in overweight and obese Saudi adults with varying glycemic levels. Lipids Health Dis 13:87.

    OpenUrl
23. 1. Al-Sofiani ME,
    2. Jammah A,
    3. Racz M,
    4. Khawaja RA,
    5. Hasanato R,
    6. El-Fawal HA,
    7. et al.

    (2015) Effect of vitamin D supplementation on glucose control and inflammatory response in type 2 diabetes: A double blind, randomized clinical trial. Int J Endocrinol Metab 13:e22604.

    OpenUrl
24. ↵
    1. Da Silva Ferreira T,
    2. Martins Rocha T,
    3. Simas Torres Klein MR,
    4. Sanjuliani AF

    (2015) Vitamin D deficiency is associated with insulin resistance independent of intracellular calcium, dietary calcium and serum levels of parathormone, calcitriol and calcium in premenopausal women. Nutr Hosp 31:1491–1498.

    OpenUrl
25. ↵
    1. Prasad P,
    2. Kochlar A

    (2015) Interplay of vitamin D and metabolic syndrome: A review. Diabetes Metab Syndr, pii: S1871-4021(15)00027-2.
26. ↵
    1. Wallace IR,
    2. Wallace HJ,
    3. McKinley MC,
    4. Bell PM,
    5. Hunter SJ

    (2015) Vitamin D and insulin resistance. Clin Endocrinol (Oxf), [Epub ahead of print].
27. ↵
    1. Bilge U,
    2. Unalacak M,
    3. Unloglu I,
    4. Ipek M,
    5. Celer O,
    6. Akalin A

    (2015) Relationship between 1, 25di-hydroxy vitamin D levels and homeostatic model assessment insulin resistance values in obese subjects. Niger J Clin Pract 18:377–380.

    OpenUrl
28. 1. Kozakowski J,
    2. Kapuscinska R,
    3. Zgliczynski W

    (2014) Associations of vitamin D concentration and metabolic and hormonal indices in women with polycystic ovary syndrome presenting abdominal and gynoidal type of obesity. Ginekol Pol 85:765–770.

    OpenUrl
29. ↵
    1. Kim HJ,
    2. Kang CK,
    3. Park H,
    4. Lee MG

    (2014) Effects of vitamin D supplementation and circuit training on indices of obesity and insulin resistance in T2D and vitamin D deficient elderly women. J Exerc Nutrition Biochem 18:249–257.

    OpenUrl
30. ↵
    1. Nigil Haroon N,
    2. Anton A,
    3. John J,
    4. Mittal M

    (2015) Effect of vitamin D supplementation on glycemic control in patients with type 2 diabetes: a systematic review of interventional studies. J Diabetes Metab Disord 14:3.

    OpenUrl
31. ↵
    1. Munoz-Aguirre P,
    2. Flores M,
    3. Macias N,
    4. Quezada AD,
    5. Denova-Gutierrez E,
    6. Salmeron J

    (2015) The effect of vitamin D supplementation on serum lipids in postmenopausal women with diabetes: A randomized controlled trial. Clin Nutr 34:799–804.

    OpenUrl
32. ↵
    1. Schnatz PF,
    2. Jiang X,
    3. Vila-Wright S,
    4. Aragaki AK,
    5. Nudy M,
    6. O’Sullivan DM,
    7. et al.

    (2014) Calcium/vitamin D supplementation, serum 25-hydroxyvitamin D concentrations, and cholesterol profiles in the Women’s Health Initiative calcium/vitamin D randomized trial. Menopause 21:823–833.

    OpenUrlCrossRefPubMed
33. ↵
    1. Chow EC,
    2. Magomedova L,
    3. Quach HP,
    4. Patel R,
    5. Durk MR,
    6. Fan J,
    7. et al.

    (2014) Vitamin D receptor activation down-regulates the small heterodimer partner and increases CYP7A1 to lower cholesterol. Gastroenterology 146:1048–1059.

    OpenUrlCrossRefPubMed
34. ↵
    1. Heravifard S,
    2. Neyestani TR,
    3. Nikooyeh B,
    4. Alavi-Majd H,
    5. Houshiarrad A,
    6. Kalayi A,
    7. et al.

    (2013) Regular consumption of both vitamin D- and calcium- and vitamin D-fortified yogurt drink is equally accompanied by lowered blood lipoprotein (a) and elevated poprotein A1 in subjects with type 2 diabetes: a randomized clinical trial. J Am Coll Nutr 32:26–30.

    OpenUrlCrossRefPubMed